Eksigent Technologies Appoints David Weber to Top Post; New Executive Brings Three Decades of Biotech Industry Experience.DUBLIN, Calif. -- Eksigent Technologies  This article about a company does not make it clear whether the subject meets the Wikipedia criteria for . , LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , creator of advanced nanofluidic technologies for life science research and medical device applications, announced today that David Weber David Mark Weber is an American science fiction and fantasy author. He was born in Cleveland, Ohio in 1952. In his stories, he creates a consistent and rationally explained technology and society. has joined the company as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , President and Director. Weber joins the company from San Diego-based Stratagene Corporation, where he was Vice President of Global Marketing and Business Development and member of the Corporate Executive Committee. He also served as President of the Americas at Amersham Biosciences from 2001 to 2004. Weber brings to Eksigent more than 30 years experience in the life science and biotechnology industries, with sales and marketing positions at companies ranging in size from start-up to over $300 million in annual sales. Carl Berg Carl Edwin Berg (born 1938) is a real estate investor and venture capitalist who has been included in Forbes Magazine's list of the 400 richest people in America numerous times. At the time the 2007 list was released, his net worth was estimated at $1.5 billion. , Eksigent Chairman of the Board and investor, stated, "We are excited to be able to attract a person of David's experience, leadership ability, and industry knowledge to lead Eksigent at this very critical stage of our development and growth. Eksigent has an incredible life science technology platform and solid, experienced management is the key ingredient needed to propel the company forward as an industry leader. David is the right person at the right time to lead Eksigent." "I am thrilled to join the Eksigent team and look forward to leading the company into the next phase of rapid growth. Eksigent couples a strong management team with outstanding technology in a way that can revolutionize life science research, drug delivery, and more," comments Weber. Mr. Weber is a graduate in biochemistry from Rutgers University Rutgers University, main campus at New Brunswick, N.J.; land-grant and state supported; coeducational except for Douglass College; chartered 1766 as Queen's College, opened 1771. Campuses and Facilities Rutgers maintains three campuses. where he was a Henry Rutgers Scholar. He earned acceptance to and is a member of Phi Beta Kappa Phi Beta Kappa: see fraternity. Phi Beta Kappa Leading academic honour society in the U.S., which draws its membership from college and university students. The oldest Greek-letter society in the U.S. . About Eksigent Eksigent Technologies is a pioneer in microfluidic systems that automate and accelerate proteomics, drug discovery, medical devices and other life science applications. Eksigent's core technologies include microscale pumping, microfluidic system design and microfabrication. The company offers solutions for nanoscale liquid chromatography, high-performance liquid chromatography and microscale pumps. For more information, visit www.eksigent.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion